Curcumin as a therapeutic agent in cancer: Progress, mechanism, and clinical prospects
Journal of Advances in Microbiology Research · 01.07.2025 · 6 (2) · 296-304
DOI: 10.22271/micro.2025.v6.i2d.266 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Advances in Microbiology Research, online erschienen am 01.07.2025. Verfasst von Chirag Dhanani und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Curcumin, a polyphenolic molecule extracted from Curcuma longa, has emerged as a promising adjuvant and therapeutic agent in cancer treatment, demonstrating anti-inflammatory, antiproliferative, and immunomodulatory properties across several malignancies. This review carefully analyzes current progress in curcumin research, clarifies the molecular processes underlying its anticancer effects, assesses therapeutic outcomes in particular cancer types, and addresses problems in clinical translation and prospective avenues for future investigation [1-89].
Zitieren
APA
Dhanani, C., & Halpani, C. (2025). Curcumin as a therapeutic agent in cancer: Progress, mechanism, and clinical prospects. Journal of Advances in Microbiology Research, 6(2), 296-304. https://doi.org/10.22271/micro.2025.v6.i2d.266
Vancouver
Dhanani C, Halpani C. Curcumin as a therapeutic agent in cancer: Progress, mechanism, and clinical prospects. Journal of Advances in Microbiology Research. 2025;6(2):296-304. doi:10.22271/micro.2025.v6.i2d.266
BibTeX
@article{Dhanani2025,
author = {Dhanani, Chirag and Halpani, Chandani},
title = {Curcumin as a therapeutic agent in cancer: Progress, mechanism, and clinical prospects},
journal = {Journal of Advances in Microbiology Research},
year = {2025},
volume = {6},
number = {2},
pages = {296--304},
doi = {10.22271/micro.2025.v6.i2d.266}
}
EUVIMED